Mavik (Trandolapril)
Medication information written by Dr. Larisa Roybal, PharmD
Updated - February 12, 2021
Mavik (Trandolapril) Medication Information
Uses
Mavik is an angiotensin converting enzyme inhibitor (ACEi) and is used to treat high blood pressure and heart failure.
Dosage
The tablets are available in different strengths:
- 1 mg
- 2 mg
- 4 mg
Side Effects
The most common side effects of Mavik include:
- Cough
- Dizziness
- Diarrhea
- Headache
Speak with your doctor for a full list of side effects that apply to you if you are taking Trandolapril .
Precautions
Mavik can cause a change in kidney function, but these changes are usually reversible when Mavik is stopped.
Trandolapril can cause an increase in potassium level, and patient will need to be monitored for this.
Mavik is an ACEi, and they can cause a benign cough. If this is bothersome, contact your provider.
Interactions
The most common drug interactions with Mavik include:
- Digoxin
- Furosemide
- Thiazide diuretics
- Cimetidine
Speak with your doctor for more information and before starting a new medication with Trandolapril .
Storage
Store at room temperature (68-77ºF).
Pharmacist Tips
- Mavik can cause fetal harm, so women taking this medication should not become pregnant.
- In patients with liver issues, a lower dose of Trandolapril should be considered.
- Mavik can be titrated to meet the needs of each individual patient
Trandolapril FAQs
What are the side effects of Mavik?
The most common side effects with Mavik are hypotension, dizziness, diarrhea, and cough.
Is Mavik a blood thinner?
Mavik is not a blood thinner, it is a medication that lowers blood pressure.
How long does Mavik stay in your system?
Trandolapril can stay in your system 30 hours after the last dose.
Is Mavik an ACE inhibitor?
Yes, Mavik is an ACE inhibitor called trandolapril.
When should I take Mavik?
Mavik is taken once a day, and it can be taken at any time of day, as long as it is at the same time every day.
Related Drugs
Reference:
Mavik {package insert}. North Chicago, IL: Abbott Laboratories; 2012.
https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020528s018lbl.pdf
Author: Dr. Larisa Roybal, PharmD
Dr. Roybal is a board-certified pharmacotherapy specialist who has practiced in both ambulatory and acute care settings. Her pharmacy interests include oncology and general inpatient pharmacy.
The above information is an educational aid only. It is not intended as medical advice for individual conditions or treatments. Talk to your doctor, nurse or pharmacist before following any medical regimen to see if it is safe and effective for you.